197 related articles for article (PubMed ID: 38604128)
1. Mutant FOXO1 controls an oncogenic network via enhancer accessibility.
Layden HM; Ellis JD; Bomber ML; Bartlett LN; Hiebert SW; Stengel KR
Cell Genom; 2024 Apr; 4(4):100537. PubMed ID: 38604128
[TBL] [Abstract][Full Text] [Related]
2. PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets.
Zhang S; Wang J; Liu Q; McDonald WH; Bomber ML; Layden HM; Ellis J; Borinstein SC; Hiebert SW; Stengel KR
Mol Cell; 2022 Dec; 82(23):4428-4442.e7. PubMed ID: 36395771
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
4. FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas.
Szydlowski M; Kiliszek P; Sewastianik T; Jablonska E; Bialopiotrowicz E; Gorniak P; Polak A; Markowicz S; Nowak E; Grygorowicz MA; Prochorec-Sobieszek M; Szumera-Cieckiewicz A; Malenda A; Lech-Maranda E; Warzocha K; Juszczynski P
Blood; 2016 Feb; 127(6):739-48. PubMed ID: 26585955
[TBL] [Abstract][Full Text] [Related]
5. Analysis of FOXO1 mutations in diffuse large B-cell lymphoma.
Trinh DL; Scott DW; Morin RD; Mendez-Lago M; An J; Jones SJ; Mungall AJ; Zhao Y; Schein J; Steidl C; Connors JM; Gascoyne RD; Marra MA
Blood; 2013 May; 121(18):3666-74. PubMed ID: 23460611
[TBL] [Abstract][Full Text] [Related]
6. CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma.
Thieme E; Bruss N; Sun D; Dominguez EC; Coleman D; Liu T; Roleder C; Martinez M; Garcia-Mansfield K; Ball B; Pirrotte P; Wang L; Xia Z; Danilov AV
Mol Cancer; 2023 Mar; 22(1):64. PubMed ID: 36998071
[TBL] [Abstract][Full Text] [Related]
7. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma.
Bogusz AM; Baxter RH; Currie T; Sinha P; Sohani AR; Kutok JL; Rodig SJ
Clin Cancer Res; 2012 Nov; 18(22):6122-35. PubMed ID: 22966017
[TBL] [Abstract][Full Text] [Related]
8. ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.
Sartori G; Napoli S; Cascione L; Chung EYL; Priebe V; Arribas AJ; Mensah AA; Dall'Angelo M; Falzarano C; Barnabei L; Forcato M; Rinaldi A; Bicciato S; Thome M; Bertoni F
J Exp Clin Cancer Res; 2021 Nov; 40(1):357. PubMed ID: 34763718
[TBL] [Abstract][Full Text] [Related]
9. Genomic Binding Patterns of Forkhead Box Protein O1 Reveal Its Unique Role in Cardiac Hypertrophy.
Pfleger J; Coleman RC; Ibetti J; Roy R; Kyriazis ID; Gao E; Drosatos K; Koch WJ
Circulation; 2020 Sep; 142(9):882-898. PubMed ID: 32640834
[TBL] [Abstract][Full Text] [Related]
10. FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism.
Sewastianik T; Szydlowski M; Jablonska E; Bialopiotrowicz E; Kiliszek P; Gorniak P; Polak A; Prochorec-Sobieszek M; Szumera-Cieckiewicz A; Kaminski TS; Markowicz S; Nowak E; Grygorowicz MA; Warzocha K; Juszczynski P
Oncogene; 2016 Nov; 35(46):5989-6000. PubMed ID: 27132507
[TBL] [Abstract][Full Text] [Related]
11. The FoxO1-ATGL axis alters milk lipolysis homeostasis through PI3K/AKT signaling pathway in dairy goat mammary epithelial cells.
He Q; Gao L; Zhang F; Yao W; Wu J; Song N; Luo J; Zhang Y
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37638641
[TBL] [Abstract][Full Text] [Related]
12. FOXO1 forkhead domain mutants in B-cell lymphoma lack transcriptional activity.
Sablon A; Bollaert E; Pirson C; Velghe AI; Demoulin JB
Sci Rep; 2022 Jan; 12(1):1309. PubMed ID: 35079069
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory regulation of FoxO1 in PPARδ expression drives mitochondria dysfunction and insulin resistance.
Park S; Cha HN; Shin MG; Park S; Kim Y; Kim MS; Shin KH; Thoudam T; Lee EJ; Wolfe RR; Dan J; Koh JH; Kim IY; Choi I; Lee IK; Sung HK; Park SY
Diabetes; 2024 Apr; ():. PubMed ID: 38656552
[TBL] [Abstract][Full Text] [Related]
14. Sporadic and endemic Burkitt lymphoma have frequent
Zhou P; Blain AE; Newman AM; Zaka M; Chagaluka G; Adlar FR; Offor UT; Broadbent C; Chaytor L; Whitehead A; Hall A; O'Connor H; Van Noorden S; Lampert I; Bailey S; Molyneux E; Bacon CM; Bomken S; Rand V
Blood Adv; 2019 Jul; 3(14):2118-2127. PubMed ID: 31300419
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of acylglycerol kinase sensitizes DLBCL to venetoclax via upregulation of FOXO1-mediated BCL-2 expression.
Ning N; Zhang S; Wu Q; Li X; Kuang D; Duan Y; Xia M; Liu H; Weng J; Ba H; Tang Z; Cheng X; Mei H; Huang L; Ao Q; Wang G; Hu Y; Laurence A; Wang J; Wang G; Yang XP
Theranostics; 2022; 12(12):5537-5550. PubMed ID: 35910796
[No Abstract] [Full Text] [Related]
16. Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis.
Roberto MP; Varano G; Vinas-Castells R; Holmes AB; Kumar R; Pasqualucci L; Farinha P; Scott DW; Dominguez-Sola D
Immunity; 2021 Aug; 54(8):1807-1824.e14. PubMed ID: 34380064
[TBL] [Abstract][Full Text] [Related]
17. Identification of Transcription Factor-Binding Sites in the Mouse FOXO1 Promoter.
Cardozo CP
Methods Mol Biol; 2019; 1890():29-40. PubMed ID: 30414142
[TBL] [Abstract][Full Text] [Related]
18. PAX3-FOXO1: Zooming in on an "undruggable" target.
Wachtel M; Schäfer BW
Semin Cancer Biol; 2018 Jun; 50():115-123. PubMed ID: 29146205
[TBL] [Abstract][Full Text] [Related]
19. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
[TBL] [Abstract][Full Text] [Related]
20. The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling.
Flori M; Schmid CA; Sumrall ET; Tzankov A; Law CW; Robinson MD; Müller A
Blood; 2016 Mar; 127(11):1438-48. PubMed ID: 26729899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
